http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011063356-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43d889455f14e81d038473dafe217881
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef1f81f2a8c9e9c3f9b47af58d14b3c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f9e3a6bd1d8c6bcd3804415b331c6c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5a35f1bccac8690e3fe5caf89045030
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-143333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0057
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-582
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-587
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0065
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06K7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02F1-35
filingDate 2010-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92926cedba9fbb190b3275ab1a36bbcb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d86ece6ac3de91d67f97d24fefa0573d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54882fa87c920340f6bdf6cd62e8799a
publicationDate 2011-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2011063356-A3
titleOfInvention Rare earth-doped up-conversion nanoparticles for therapeutic and diagnostic applications
abstract This invention provides a composition matter comprising rare earth-doped up-conversion nanoparticles (UCNPs) encapsulated with a silica shell. In one embodiment, a photosensitizer is incorporated into the silica shell. In another embodiment, the composition further comprises a targeting molecule. In still another embodiment, a small interfering RNA (siRNA) molecule is also attached to the silica shell with the targeting molecule. The invention further provides methods for synthesizing such compositions and for using them in therapeutic and diagnostic applications. These applications use infrared or near infrared activation to excite the UCNPs.
priorityDate 2009-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009074828-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007212542-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009061010-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008253961-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004010218-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758

Total number of triples: 33.